It wasn’t just the lure of a 10-minute commute from his suburban Boston home that prompted John Reynders to join AstraZeneca (AZ) as head of R&D Information some 18 months ago, after stints at Celera (Maryland), Lilly (Indianapolis), and J&J (New Jersey). Rather it was the diversity of skills among his team of some 400 people, with expertise ranging from clinical informatics and knowledge engineering to software architects and business intelligence, and the company’s belief in innovation and long-range strategic planning.